← Eichor
Study identifier: NCT07671846 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Patient Anxiety During Magnetic Resonance Imaging

Condition: Cancer  ·  Sponsor: European Institute of Oncology

PhaseN/A
Planned participants175
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is a cross-sectional validation project that aims to translate the MRI-Anxiety Questionnaire (MRI-AQ) into Italian and adapt it culturally for cancer patients undergoing whole-body MRI. The protocol will recruit 175 adult patients at the European Institute of Oncology, use a forward-backward translation process, and evaluate the Italian version with the MRI-AQ itself plus the MRI Fear Survey Schedule (MRI-FSS). The main statistical goal is to show that the Italian version is not inferior to the original in terms of internal consistency. The ultimate purpose is to provide a specific, validated tool for measuring MRI-related anxiety in Italian oncology patients.

This description comes directly from the study's public registry record.

Talk to the study team

Giuseppe Petralia, PhD  ·  +39 0257489037  ·  giuseppe.petralia@ieo.it

Always discuss trial participation with your own doctor first.

Locations (1)

European Institute of Oncology, MilanMilan, Mi, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07671846